Videos

Advanced ovarian cancer is deadly for female patients with the disease, but results from a new study show promise for a new frontline treatment.

For patients with breast cancer with a PDL1 expression, a new treatment targeting immune cells could make a major difference.

While the findings from the most recent CARD study prove promising, it's the toxicity results that have one expert excited.

For patients with advanced prostate cancer, new findings from the CARD trial could change their daily treatment.

When patients with MCL develop resistance to chemotherapy and targeted therapies, experts believe CAR T-cell therapy can step in.

CAR T-cell therapies are a revolutionary form of treatment for patients with cancer, but it does come with its unique adverse events.

CAR T-cell therapy is changing the landscape of cancer care, but challenges for certain cancer types still remain.

Pediatric patients with ALL can expect therapies to help target their disease after they relapse, but experts are looking to combat the disease in the frontline before that.

About a third of breast cancer survivors are still living with fatigue and reduced exercise capacity after treatment ends.

While some view immunotherapy as limiting in small-cell lung cancer treatment, one expert believes otherwise.

Financial toxicity can have an impact on patients' anxiety and depression, but oncology nurses can help.

While treatment options for lung cancer have vastly improved over the last decade, attitudes toward the disease have actually gotten worse.

Due to their strict regulations, clinical trials eliminate room for discriminatory practices, and can lend insight to disparities among groups.

Don't waste time being upset, and don't try to shield loved ones from their diagnosis.

From long-term data to additional clinical trials, more is needed to better understand immunotherapy in lung cancer.

An expert gives an overview of the different treatment approaches for patients with breast cancer that has metastasized to their brain.

It is crucial for nurses to be aware of adverse events that can occur in patients who are receiving CAR T-cell therapy, explained one expert.

There are certain comorbidities and lifestyle factors that practitioners must consider before prescribing treatment for chronic myelogenous leukemia.

A new surgical method could help treat lymphedema, according to one expert.

Certain racial groups had a higher incidence of early-onset colorectal cancer, according to recent research.

A grateful patient recognizes all the hard work that goes into their treatment and care, explained former NFL player Rolf Benirschke.

Oncology nurses brightened the mood of Kerry Fraser's first oncology appointment.

Liquid biopsies and other novel techniques have the potential to change the bladder cancer space. However, unanswered questions remain.

Patients with CLL prescribed BTK inhibitors may have a higher chance of developing secondary cancers, according to recent research.

Cancer-related cognitive impairments affect many survivors of the disease, and can have major impacts on their daily living.

One expert discusses findings from the TAILORx study.

Nurses, other clinicians, and outside organizations must work together to ensure that all patients' needs and concerns are being addressed.

There is so much important and actionable clinical data found in clinicians' notes in electronic medical records (EMRs).